Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Multi-Omics Network of a Seven-Gene Prognostic Signature for Non-Small Cell Lung Cancer

25 Dec 2021

Abstract excerpt

There is an unmet clinical need to identify patients with early-stage non-small cell lung cancer (NSCLC) who are likely to develop recurrence and to predict their therapeutic responses. Our previous study developed a qRT-PCR-based seven-gene microfluidic assay to predict the recurrence risk and the clinical benefits of chemotherapy. This study showed it was feasible to apply this seven-gene panel in RNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Lung Cancer Treatments and Mutations
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35008645
DOI: 10.3390/ijms23010219

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Multi-Omics Network of a Seven-Gene Prognostic Signature for Non-Small Cell Lung CancerPMID 35008645Read ↗

Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and SurvivalSemantic proximity Read ↗

Identification of seven-gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi-omics data analysis.Semantic proximity Read ↗

Immune-Omics Networks of CD27, PD1, and PDL1 in Non-Small Cell Lung CancerSemantic proximity Read ↗

A 23-gene multi-omics signature predicts prognosis and treatment response in non-small cell lung cancerSemantic proximity Read ↗

Integrated Multi-Omics Analysis Identifies Key Genes and Drug Candidates in Non-Small Cell Lung CancerSemantic proximity Read ↗

Integrated Multi-Omics Analysis of Lung Adenocarcinoma (TCGA-LUAD): A Comprehensive Study of Genomic, Epigenomic, Copy Number Variations, and Transcriptomic AlterationsSemantic proximity Read ↗

Integrated Multi-Omics Signature Predicts Survival in Head and Neck CancerSemantic proximity Read ↗

Identification of Biomarker Genes Based on Multi-Omics Analysis in Non- Small Cell Lung CancerSemantic proximity Read ↗

Integrative analysis of multi-omics data reveals the heterogeneity and signatures of immune therapy for small cell lung cancerSemantic proximity Read ↗

SCLC TumorMiner: A Genomics Platform for Small Cell Lung Cancer Precision OncologySemantic proximity Read ↗

Uncovering Prognosis-Related Genes and Pathways by Multi-Omics Analysis in Lung CancerSemantic proximity Read ↗

GASPS: A Multi-Omics Framework for Defining Genomic Aberration-Driven Signatures and Predicting Patient Outcomes in Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.